INSPHERO

In News

InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Business Wire

Business Wire - May 20, 2026

InSphero acquires PhenoVista to expand US presence - Startupticker.ch

Startupticker.ch - May 26, 2026

InSphero 3D InSight Microtissues enable scalable, assay-ready drug discovery workflows - Select Science

Select Science - Jun 25, 2026

InSphero - 2026 Funding Rounds & List of Investors - Tracxn

Tracxn - Aug 25, 2026

InSphero and FDA Scientists Publish Benchmark Study for Drug Safety Assessment - Physicians Committee for Responsible Medicine

Physicians Committee for Responsible Medicine - Nov 01, 2024

Sugar-coated stem cells heal damaged livers — replacing transplants - The Brighter Side of News

The Brighter Side of News - Oct 29, 2025

InSphero acquires DOPPL SA and Sun Bioscience Gri3D Technology - Startupticker.ch

Startupticker.ch - Nov 12, 2025

Scailyte Announces Jan Lichtenberg, CEO at inSphero, as a Member of the Board of Directors - Newswire.com

Newswire.com - May 09, 2023

Prediction of Liver Toxicity Revolutionized in Largest 3D In Vitro Benchmarking Study - technologynetworks.com

technologynetworks.com - Jan 03, 2025

Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model - Nature

Nature - Mar 11, 2024

Detecting hepatotoxic drugs with human liver microtissues - News-Medical

News-Medical - Nov 18, 2024

Getting the Hang of 3D Liver Microtissues - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Jun 29, 2016

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment